pioglitazone has been researched along with Carditis in 6 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Excerpt | Relevance | Reference |
---|---|---|
"We investigated the long-term effects of the thiazolidinedione PPARgamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats (SHRSP), a model of malignant of hypertension." | 7.72 | Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats. ( Amiri, F; Benkirane, K; Diep, QN; Paradis, P; Schiffrin, EL, 2004) |
"We investigated the long-term effects of the thiazolidinedione PPARgamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats (SHRSP), a model of malignant of hypertension." | 3.72 | Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats. ( Amiri, F; Benkirane, K; Diep, QN; Paradis, P; Schiffrin, EL, 2004) |
" Then the rats were divided into 3 groups of 9 rats: PPAR-gamma ligand 15-deoxy-(12,14)-PGJ(2) (15d-PGJ(2)) group (15d-PGJ(2) was injected intraperitoneally at the dosage of 200 microg." | 1.32 | [Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity]. ( Kishimoto, C; Liu, Y; Liu, ZQ; Yuan, ZY; Zhang, JJ, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yuan, Z | 3 |
Liu, Y | 8 |
Zhang, J | 3 |
Kishimoto, C | 4 |
Wang, Y | 2 |
Ma, A | 3 |
Liu, Z | 3 |
Yuan, ZY | 1 |
Zhang, JJ | 1 |
Liu, ZQ | 1 |
Diep, QN | 1 |
Amiri, F | 1 |
Benkirane, K | 1 |
Paradis, P | 1 |
Schiffrin, EL | 1 |
Hasegawa, H | 1 |
Takano, H | 1 |
Zou, Y | 1 |
Qin, Y | 1 |
Hizukuri, K | 1 |
Odaka, K | 1 |
Toyozaki, T | 1 |
Komuro, I | 1 |
6 other studies available for pioglitazone and Carditis
Article | Year |
---|---|
Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis.
Topics: Animals; Autoimmune Diseases; Hypoglycemic Agents; Interleukin-1; Models, Animal; Myocarditis; Piogl | 2003 |
[Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity].
Topics: Animals; Autoimmune Diseases; Immunosuppressive Agents; Myocarditis; Pioglitazone; Prostaglandin D2; | 2003 |
Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells.
Topics: Animals; Autoimmune Diseases; Cells, Cultured; Dose-Response Relationship, Drug; Ligands; Myocarditi | 2004 |
Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Hypertension; Hypertrophy, Left Ventricular; Male; Myocarditis; Pioglitazone; PPAR gamma; R | 2004 |
Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance.
Topics: Animals; Autoimmune Diseases; Body Weight; Cytokines; Disease Models, Animal; Female; Hemodynamics; | 2005 |
Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade.
Topics: Acute Disease; Animals; Autoimmune Diseases; Cardiotonic Agents; Cytokines; Gene Expression Regulati | 2005 |